OMC vs STRO
Omnicom Group Inc (OMC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported OMC revenue for 2024-12-31 was $15.69B. Net income was $1.57B. Revenue was up 6.8% from 2023-12-31 to 2024-12-31. OMC currently screens at market cap $21.75B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
OMC currently screens at market cap $21.75B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the OMC and STRO stock pages for the full models.
Not investment advice.